New York, June 11, 2026, 06:06 EDT
- UiPath shares last traded at $10.75, flat from the previous close.
- PATH ended unchanged on June 10. Shares had dropped 3.76% on June 9, with the stock holding close to the bottom of its latest range.
- UiPath shares are trading under the $11.47 average that the company paid per Class A share repurchased in the April quarter.
UiPath Inc. stayed stuck around $10.75 early Thursday as traders weighed the company’s better profits and stock buyback against ongoing questions about its AI-related growth. Shares didn’t move much compared to yesterday: PATH finished flat on June 10 after sliding 3.76% on June 9, and the latest price barely shifted.
So today’s move isn’t tied to any new announcement. UiPath’s investor-relations site shows a June 4 Form 10-Q and a May 28 Form 8-K as the latest SEC filings. The action in the stock looks like investors are still working through the earnings, guidance, and capital-return update, not any fresh headline.
UiPath’s buyback stands out. The company disclosed in its 10-Q that it bought back 20.4 million Class A shares in the quarter ended April 30, paying an average of $11.47 per share, commissions included. PATH is trading near $10.75, so the market price now sits below where UiPath was buying in earlier this year.
Bulls got new material after UiPath’s latest results. Revenue climbed to $418.4 million for the April quarter, compared with $356.6 million in the same period a year ago. UiPath swung to net income of $22.5 million, after posting a loss last year. Annualized renewal run-rate (ARR) hit $1.901 billion, up 12% on the year.
Profit dragged the valuation talk into sharper focus. UiPath posted $28 million in GAAP operating income for the quarter, with non-GAAP operating income at $92 million. That non-GAAP number strips out some costs, including stock-based comp. Cash, cash equivalents and marketable securities totaled $1.42 billion at the end of April.
UiPath management says the company isn’t just about robotic process automation anymore. RPA, or RPA, is bots taking care of repetitive tasks like data entry or shuffling data between apps. Now, UiPath wants to move into so-called “agentic” automation. That’s where AI systems plan out and complete more complicated tasks with less human oversight. UiPath
UiPath CEO Daniel Dines kept focus on AI in the last earnings release, saying the company’s “agentic products are moving from pilot to production.” In May, UiPath rolled out UiPath for Coding Agents, which it says works with coding agents like Claude Code and OpenAI Codex. The company says it is adding governance, audit and deployment controls for businesses. UiPath, Inc.
But the stock just isn’t seeing the kind of action you’d expect if investors were on board with the AI acceleration pitch. UiPath put out guidance for second-quarter fiscal 2027 revenue of $395 million to $400 million, with ARR forecast at $1.929 billion to $1.934 billion as of July 31. The full-year revenue outlook came in at $1.776 billion to $1.781 billion, ARR at $2.058 billion to $2.063 billion.
ARR growth gives investors a direct read on whether clients are putting more money into automation or just sticking with what they have. UiPath reported a dollar-based net retention rate of 109%. So existing customers spent more than last year, though not at a blowout rate that would mark the stock as an AI standout.
Wall Street stays cautious. Benzinga’s analyst roundup puts the consensus at Neutral with a $14.48 price target. BMO Capital’s last call, posted June 1, kept its Market Perform rating and a $13 target. That offers some support against the current price, but it’s not a strong buy signal.
UiPath’s AI products look strong in demos, but the risk is they won’t drive faster ARR growth. Customers might put off automation work. Rivals and model vendors could package similar workflow tools in bigger platforms. Rules or worries on AI agents could slow sales. UiPath itself flagged that its results hang on customer retention, new features, AI rules, third-party cloud and language-model providers, competition, the economy, and swings in its Class A stock.
UiPath faces a clear test now: can it deliver Q2 ARR in the $1.929 billion to $1.934 billion band and keep the profit discipline seen in April? If it misses, the stock trading under its own recent buyback level could look more like the market sending a warning than a chance to buy.
Related articles: NYSE:PATH
